药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tolazamide
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Saquinavir.
Tolazamide
Anisodamine
The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Saquinavir.
Tolazamide
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Saquinavir.
Tolazamide
Bilastine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Saquinavir.
Tolazamide
Difloxacin
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Saquinavir.
Tolazamide
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Saquinavir.
Tolazamide
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Saquinavir.
Tolazamide
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Saquinavir.
Tolazamide
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Saquinavir.
Tolazamide
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Saquinavir.
Tolazamide
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Saquinavir.
Tolazamide
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Saquinavir.
Tolazamide
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Saquinavir.
Tolazamide
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Saquinavir.
Tolazamide
Indenolol
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Saquinavir.
Tolazamide
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Saquinavir.
Tolazamide
Eribulin
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Saquinavir.
Tolazamide
Bupranolol
The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Saquinavir.
Tolazamide
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Saquinavir.
Tolazamide
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Saquinavir.